202 related articles for article (PubMed ID: 21092100)
1. Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review.
Plested M; Budhia S; Gabriel Z
BMC Neurol; 2010 Nov; 10():116. PubMed ID: 21092100
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
Ritchie M; Liedgens H; Nuijten M
Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
4. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
[TBL] [Abstract][Full Text] [Related]
5. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Mittal M; Pasnoor M; Mummaneni RB; Khan S; McVey A; Saperstein D; Herbelin L; Ridings L; Wang Y; Dimachkie MM; Barohn RJ
Int J Neurosci; 2011 Sep; 121(9):521-7. PubMed ID: 21671841
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
Liedgens H; Hertel N; Gabriel A; Nuijten M; Dakin H; Mitchell S; Nautrup BP
Clin Drug Investig; 2008; 28(9):583-601. PubMed ID: 18666805
[TBL] [Abstract][Full Text] [Related]
7. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.
Katz P; Pegoraro V; Liedgens H
Curr Med Res Opin; 2017 Aug; 33(8):1481-1489. PubMed ID: 28537441
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
10. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
[TBL] [Abstract][Full Text] [Related]
11. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study.
Rehm S; Binder A; Baron R
Curr Med Res Opin; 2010 Jul; 26(7):1607-19. PubMed ID: 20429825
[TBL] [Abstract][Full Text] [Related]
12. Pain alleviation and patient-reported health outcomes following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain in routine medical practice.
Saldaña MT; Pérez C; Navarro A; Masramón X; Rejas J
Clin Drug Investig; 2012 Jun; 32(6):401-12. PubMed ID: 22480279
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of pharmacoeconomic studies for pregabalin.
Parker L; Huelin R; Khankhel Z; Wasiak R; Mould J
Pain Pract; 2015 Jan; 15(1):82-94. PubMed ID: 24815038
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Pregabalin and Intraoperative Lidocaine Infusion to Reduce Persistent Neuropathic Pain After Breast Cancer Surgery: A Multicenter, Factorial, Randomized, Controlled Pilot Trial.
Khan JS; Hodgson N; Choi S; Reid S; Paul JE; Hong NJL; Holloway C; Busse JW; Gilron I; Buckley DN; McGillion M; Clarke H; Katz J; Mackey S; Avram R; Pohl K; Rao-Melacini P; Devereaux PJ
J Pain; 2019 Aug; 20(8):980-993. PubMed ID: 30844507
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin.
Buksnys T; Armstrong N; Worthy G; Sabatschus I; Boesl I; Buchheister B; Swift SL; Noake C; Huertas Carrera V; Ryder S; Shah D; Liedgens H; Kleijnen J
Curr Med Res Opin; 2020 Jan; 36(1):101-115. PubMed ID: 31469302
[No Abstract] [Full Text] [Related]
16. Treatment of neuropathic pain: an overview of recent guidelines.
O'Connor AB; Dworkin RH
Am J Med; 2009 Oct; 122(10 Suppl):S22-32. PubMed ID: 19801049
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
[TBL] [Abstract][Full Text] [Related]
19. Nortriptyline for neuropathic pain in adults.
Derry S; Wiffen PJ; Aldington D; Moore RA
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011209. PubMed ID: 25569864
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.
Boyle J; Eriksson ME; Gribble L; Gouni R; Johnsen S; Coppini DV; Kerr D
Diabetes Care; 2012 Dec; 35(12):2451-8. PubMed ID: 22991449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
